Cytodyn Inc (CYDY)

[C-20]

Nope not at all what’s happening, need I remind everyone this is the same company that brought us Remdeathisnear and we all know how that is working out. There so called trial for NASH includes 70 or so patients with results far less than our results around 70% or so. That is good enough for approval but ours is showing much higher efficacy with far less patients but our trial is ongoing as well. At least this drug is not dangerous like Remdeathisnear. The point is this , it’s not better than LL it has a 100% chance of approval because it is produced by BP , the fortunate thing is that it will take more than one drug to combat NASH . Just like the covid vaccines had 3 different drugs approved all big pharma and all approved at virtually the same time…… hmmmm! It doesn’t have near the indications that LL has . Another hit article this morning is music to my ears and will have little to no effect on the SP as a matter of fact I’m picking up more shares first thing Monday as we are on the verge of big time news.